Regulatory Knowledge and PV Governance Copilot

An AI and data governance application for biopharma that supports explainable clinical development prediction, regulatory-science knowledge retrieval and question answering, and governed AI automation for hybrid pharmacovigilance operations.

The Problem

“Pharmaceutical AI Governance and Regulatory Knowledge Copilot”

Organizations face these key challenges:

1

Clinical development data is complex, heterogeneous, and difficult to interpret quickly with confidence

2

Regulatory-science content is dense, frequently updated, and spread across many sources

3

Pharmacovigilance workloads are growing faster than internal teams can scale

4

Regulated operations require explainability, provenance, validation, and auditability

Impact When Solved

Reduce time to answer regulatory-science questions from hours to minutes with cited responsesImprove clinical development decision support using explainable predictive models over trial, biomarker, and operational dataIncrease pharmacovigilance case-processing throughput with human-in-the-loop automationStandardize AI governance with model registry, prompt/version control, audit logs, and approval workflows

The Shift

Before AI~85% Manual

Human Does

  • •Search guidance, literature, SOPs, and policy documents to answer regulatory-science questions
  • •Review trial, biomarker, and operational data manually to form clinical development recommendations
  • •Coordinate pharmacovigilance intake, case review, and routing through SOP-driven handoffs with partners
  • •Document rationale, provenance, and approvals in spreadsheets, email trails, and quality records

Automation

  • •Provide basic keyword search across document repositories
  • •Generate static reports or dashboards from siloed analytics tools
  • •Apply limited rule-based checks in fragmented safety workflows
With AI~75% Automated

Human Does

  • •Approve cited regulatory answers and interpret implications for regulated decisions
  • •Review explainable clinical predictions and decide actions on trials, sites, or milestones
  • •Approve pharmacovigilance case decisions, resolve low-confidence exceptions, and oversee partner handoffs

AI Handles

  • •Retrieve and synthesize regulatory-science content into cited answers with confidence and source provenance
  • •Analyze clinical development data to generate explainable risk predictions and decision-support summaries
  • •Triage pharmacovigilance work by classifying cases, detecting duplicates, drafting narratives, and routing tasks by policy
  • •Monitor model, prompt, and workflow activity with lineage, versioning, audit logs, and compliance alerts

Operating Intelligence

How it works

AI runs the first three steps autonomously.

Humans own every decision.

The system gets smarter each cycle.

Confidence88%
ArchetypeRecommend & Decide
Shape6-step converge
Human gates1
Autonomy
67%AI controls 4 of 6 steps

Who is in control at each step

Each column marks the operating owner for that step. AI-led actions sit above the divider, human decisions and feedback loops sit below it.

Loop shapeconverge

Step 1

Assemble Context

Step 2

Analyze

Step 3

Recommend

Step 4

Human Decision

Step 5

Execute

Step 6

Feedback

AI lead

Autonomous execution

1AI
2AI
3AI
5AI
gate

Human lead

Approval, override, feedback

4Human
6↺ Loop
AI-led step
Human-controlled step
Feedback loop
TL;DR

AI handles assembly, analysis, and execution. The human gate sits at the decision point. Every cycle refines future recommendations.

The Loop

6 steps

1 operating angles mapped

Operational Depth

Real-World Use Cases

LLM support for regulatory-science knowledge retrieval and question answering

Ask questions in plain language about complex medicines-regulation information and have the model help find or explain relevant content.

semantic retrieval and question answeringproposed/considered use under guiding principles; requires careful controls for accuracy and traceability.
10.0

FSP-partnered hybrid pharmacovigilance operations with AI automation

Companies combine outside pharmacovigilance partners with AI tools so safety work can be done faster and at larger scale without losing oversight.

Workflow augmentation for regulated operationsproposed and increasingly practical operating model as ai platforms and llms have become more accessible since 2022.
10.0

AI-driven predictive analysis for clinical development

AI models analyze clinical research data to spot patterns and help teams make better development decisions sooner.

Predictive analytics and decision supportemerging but actively deployed capability within an established platform.
10.0

Free access to this report